Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study

计划入组 500 人 · 首次发布于 2010 年 6 月 29 日

Long Study - Longitudinal Thrombosis in End Stage Renal Disease

计划入组 400 人 · 首次发布于 2005 年 9 月 12 日

Cognitive Impairment and Imaging Correlates in End Stage Renal Disease

计划入组 120 人 · 首次发布于 2013 年 6 月 21 日

cell therapy (end stage renal disease)

Lanthanum carbonate(Fosrenol)

C₃La₂O₉ · Rx

Calcium acetate(Domeboro, Eliphos, Phoslo, Phoslyra, Procalamine 3)

C₄H₆CaO₄

Cadrenal Therapeutics

United States

RENAL DISEASE RESEARCH INSTITUTE, LLC

United States

DaVita

United States

Humacyte Presents Positive Phase 3 Data for Tissue-Engineered Vessel in Hemodialysis Access

Xeltis' aXess Receives FDA Breakthrough Device Designation and Enrolls First Patient in Pivotal Trial

Xeltis Completes Enrollment in EU Pivotal Trial for aXess Vascular Access Conduit